Updated Jul 16, 2026
Haller Julia A has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Julia A. Haller is a corporate director at Outlook Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on ophthalmic treatments. She has been involved in the company's SEC filings as a director, although specific details about her career outside of this role are not widely known.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-16 | BMY | BRISTOL MYERS SQUIBB CO | M — Option exercise | 20.5K | $53.76 | $1.10M |
Julia A. Haller is a corporate director at Outlook Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on ophthalmic treatments. She has been involved in the company's SEC filings as a director, although specific details about her career outside of this role are not widely known.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Haller Julia A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.